WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Amin, Elianna M., Oltean, Sebastian, Hua, Jing, Gammons, Melissa V.R., Hamdollah-Zadeh, Maryam, Welsh, Gavin I., Cheung, Man-Kim, Ni, Lan, Kase, Satoru, Rennel, Emma S., Symonds, Kirsty E., Nowak, Dawid G., Royer-Pokora, Brigitte, Saleem, Moin A., Hagiwara, Masatoshi, Schumacher, Valérie A., Harper, Steven J., Hinton, David R., Bates, David O., Ladomery, Michael R.
Published in Cancer cell (13.12.2011)
Published in Cancer cell (13.12.2011)
Get full text
Journal Article
Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density
Emmett, Maxine S, Symonds, Kirsty E, Rigby, Howard, Cook, Martin G, Price, Rebecca, Metcalfe, Chris, Orlando, Antonio, Bates, David O
Published in BMC cancer (17.05.2010)
Published in BMC cancer (17.05.2010)
Get full text
Journal Article
Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab
BATES, David O, CATALANO, Paul J, SYMONDS, Kirsty E, VAREY, Alex H. R, RAMANI, Pramila, O'DWYER, Peter J, GIANTONIO, Bruce J, MEROPOL, Neal J, BOWEN BENSON, Al, HARPER, Steven J
Published in Clinical cancer research (15.11.2012)
Published in Clinical cancer research (15.11.2012)
Get full text
Journal Article
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance
Hamdollah Zadeh, Maryam A., Amin, Elianna M., Hoareau-Aveilla, Coralie, Domingo, Enric, Symonds, Kirsty E., Ye, Xi, Heesom, Katherine J., Salmon, Andrew, D'Silva, Olivia, Betteridge, Kai B., Williams, Ann C., Kerr, David J., Salmon, Andrew H.J., Oltean, Sebastian, Midgley, Rachel S., Ladomery, Michael R., Harper, Steven J., Varey, Alexander H.R., Bates, David O.
Published in Molecular oncology (01.01.2015)
Published in Molecular oncology (01.01.2015)
Get full text
Journal Article
Predictive value of the antiangiogenic VEGF splice variant expression for bevacizumab efficacy in the phase III trial of bevacizumab and FOLFOX4 versus FOLFOX4 in previously treated patients with advanced colorectal cancer (ECOG E3200T2)
Bates, David O., Catalano, Paul J., Symonds, Kirsty E., Varey, Alexander H. R., Ramani, Pramila, O'Dwyer, Peter James, Giantonio, Bruce J., Meropol, Neal J., Benson, Al Bowen, Harper, Steven J.
Published in Journal of clinical oncology (01.02.2012)
Published in Journal of clinical oncology (01.02.2012)
Get full text
Journal Article